RB1 and cancer: The retinoblastoma tumor suppressor (RB), which is lost or functionally inactivated in most cancers (Burkhart & Sage, 2008), is best known for its role as a negative regulator of E2F-dependent transcription (Dyson, 1998; Nevins, 2001).